How Will a Rebate Model Impact Cash Flow in the 340B Drug Pricing Program?制药/制药装备药品IQVIA2025-12-2128 页
FDA’s Rare Disease Evidence Principles (RDEP): Use Real-World Evidence in Ultra-Rare Drug Development制药/制药装备执法/稽查/监督罕见病美国/美国经济民生/美国消费者药品IQVIA2026-01-237 页
医药行业周报(1.19-1.23):显著提速,关注双抗、ADC、GLP-1RA、小核酸等方向——2025 年药品BD 出海回顾出海创新药制药/制药装备券商证券核酸药品西南证券研究院2026-01-2532 页
Overview of ePI Pilots in 31 European Countries制药/制药装备欧洲/欧盟电子信息药品IATF-ePI (AESGP, Efpia, Medicines for Europe)2026-02-2533 页